Patient level dosimetry for radionuclide therapy: proof of concept for patients receiving 177Lu-DOTATATE

被引：0
|
作者：
St James, Sara [3 ]
Padilla-Morales, Erika [2 ]
Bergsland, Emily [1 ]
Hope, Thomas [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Nucl Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Radiat Oncol, San Francisco, CA 94143 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1632
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patient-Specific Dosimetry of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy with High Activities
    Beykan, S.
    Eberlein, U.
    Werner, R. A.
    Lapa, C.
    Buck, A. K.
    Kudlich, T.
    Lassmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S33 - S33
  • [2] Biphasic exponential dosimetry model for 177Lu-DOTATATE peptide receptor radionuclide therapy
    Chen, Sirong
    Cheng, Kam
    Li, Ka Chun
    Leung, Yim Lung
    Cheung, William
    Wong, Ka Nin
    Wong, Yuet Hung
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [3] Establishing a clinical dosimetry protocol for 177Lu-DOTATATE peptide receptor radionuclide therapy
    Bissell, S.
    Ross, E.
    McMeekin, H.
    Seal, E.
    Ogunwale, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S106 - S106
  • [4] 177Lu-DOTATATE Quantification for Patient Personalised Dosimetry in Therapy of Neuroendocrine Tumours
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, D. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S656 - S656
  • [5] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [6] Understanding The Radiobiology Of Targeted Radionuclide Therapy With 177lu-dotatate
    Delbart, W.
    Wimana, Z.
    Vercruyssen, M.
    Meuleman, N.
    Ghanem, G.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S13 - S14
  • [7] 177Lu-DOTATATE receptor radionuclide therapy: Internal dosimetry estimates and considerations for practical protocols
    Cremonesi, Marta
    Di Dia, Giuseppina Amalia
    Bodei, Lisa
    Botta, Francesca
    Ferrari, Mahila
    De Cicco, Concetta
    Prisco, Gennaro
    Pedroli, Guido
    Paganelli, Giovanni
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [8] Towards a quality assurance for dosimetry in peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE
    Marin, G.
    Vanderlinden, B.
    Wimana, Z.
    Guiot, T.
    Karfis, I.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S159 - S160
  • [9] Individualized dosimetry in patients with metastatic neuroendocrine tumours after treatment with 177Lu-Dotatate targeted radionuclide therapy
    Kalogianni, E.
    Dunlop, A.
    Corcoran, B.
    Hooker, C.
    Devlin, L.
    Mulholland, N.
    Vivian, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S308 - S308
  • [10] Dosimetry in patients undergoing 177Lu-DOTATATE therapy with indications for 90Y-DOTATATE
    Cremonesi, M.
    Ferrari, M. E.
    Bodei, L.
    Bartolomei, M.
    Chinol, M.
    Mei, R.
    Daou, B.
    Tosi, G.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S102 - S102
12345